Furthermore, unbound IgE-Fc maintains a bent configuration, while IgE-Fc is partly bent when it is bound to omalizumab's Fab fragment, which is an anti-IgE in clinical use for the treatment of allergy [10]. The gene discussed is IGHE; the disease is allergic disease.